Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial

The Lancet

Volumn 390, Issue 10098, 2017, Pages 959-968

  de Jong, Marin J ^a   van der Meulen de Jong, Andrea E ^b   Romberg Camps, Mariëlle J ^c   Becx, Marco C ^d   Maljaars, Jeroen P ^b   Cilissen, Mia ^a   van Bodegraven, Ad A ^c   Mahmmod, Nofel ^d   Markus, Tineke ^e   Hameeteman, Wim M ^a   Dijkstra, Gerard ^f   Masclee, Ad A ^a   Boonen, Annelies ^a   Winkens, Bjorn ^g   van Tubergen, Astrid ^a   Jonkers, Daisy M ^a   Pierik, Marie J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e CCUVN   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; EMERGENCY CARE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; STATISTICAL SIGNIFICANCE; TELEMEDICINE; ULCERATIVE COLITIS; VISUAL ANALOG SCALE; ADOLESCENT; AMBULATORY CARE; CLINICAL TRIAL; DISEASE MANAGEMENT; INFLAMMATORY BOWEL DISEASE; MIDDLE AGED; NETHERLANDS; PRIMARY HEALTH CARE; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DISEASE MANAGEMENT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NETHERLANDS; OFFICE VISITS; PRIMARY HEALTH CARE; SELF CARE; TELEMEDICINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85023773744     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31327-2     Document Type: Article

References (32)

1. Burisch, J, Munkholm, P, The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 50 (2015), 942–951.
2. Magro, F, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis, 2017 published online Feb 2. DOI:10.1093/ecco-jcc/jjx008.
3. Gomollón, F, 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis 11 (2016), 3–25.
4. Jeuring, SF, van den Heuvel, TR, Liu, LY, et al. Improvements in the long-term outcome of Crohn's disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort. Am J Gastroenterol 112 (2016), 325–336.
5. Jeuring, SF, Bours, PH, Zeegers, MP, et al. Disease outcome of ulcerative colitis in an era of changing treatment strategies: results from the Dutch population-based IBDSL cohort. J Crohns Colitis 9 (2015), 837–845.
6. Colombel, JF, Narula, N, Peyrin-Biroulet, L, Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology, 152, 2017, 351 61.e5.
7. Pedersen, N, Thielsen, P, Martinsen, L, et al. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis 20 (2014), 2276–2285.
8. Lakatos, PL, Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?. World J Gastroenterol 15 (2009), 4234–4239.
9. Reigada, LC, Satpute, A, Hoogendoorn, CJ, et al. Patient-reported anxiety: a possible predictor of pediatric inflammatory bowel disease health care use. Inflamm Bowel Dis 22 (2016), 2127–2133.
10. Porter, ME, What is value in health care?. N Engl J Med 363 (2010), 2477–2481.
11. Bradley, SM, Rumsfeld, JS, Ho, PM, Incorporating health status in routine care to improve health care value: the VA Patient Reported Health Status Assessment (PROST) System. JAMA 316 (2016), 487–488.
12. Siegel, CA, Allen, JI, Melmed, GY, Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11 (2013), 908–912.
13. Melmed, GY, Siegel, CA, Spiegel, BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis 19 (2013), 662–668.
14. de la Torre Diez, I, Garcia-Zapirain, B, Mendez-Zorrilla, A, Lopez-Coronado, M, Monitoring and follow-up of chronic heart failure: a literature review of eHealth applications and systems. J Med Syst, 40, 2016, 179.
15. Jonkman, NH, Westland, H, Trappenburg, JC, et al. Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis. Int J Chron Obstruct Pulmon Dis 11 (2016), 2063–2074.
16. Aguas, M, Del Hoyo, J, Faubel, R, Nos, P, Telemedicine in inflammatory bowel disease: opportunity ahead. Inflamm Bowel Dis 22 (2016), E4–E5.
17. Huang, VW, Reich, KM, Fedorak, RN, Distance management of inflammatory bowel disease: systematic review and meta-analysis. World J Gastroenterol 20 (2014), 829–842.
18. Jackson, BD, Gray, K, Knowles, SR, De Cruz, P, EHealth technologies in inflammatory bowel disease: a systematic review. J Crohns Colitis 10 (2016), 1103–1121.
19. Elkjaer, M, Shuhaibar, M, Burisch, J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach. Gut 59 (2010), 1652–1661.
20. Cross, RK, Cheevers, N, Rustgi, A, Langenberg, P, Finkelstein, J, Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis 18 (2012), 1018–1025.
21. Pedersen, N, Elkjaer, M, Duricova, D, et al. eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease. Aliment Pharmacol Ther 36 (2012), 840–849.
22. de Jong, M, van der Meulen-de Jong, A, Romberg-Camps, M, et al. Development and feasibility study of a telemedicine tool for all patients with IBD: MyIBDcoach. Inflamm Bowel Dis 23 (2017), 485–493.
23. Lennard-Jones, JE, Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170 (1989), 2–6 discussion 16–19.
24. de Jong, M, van den Heuvel, T, Romberg-Camps, M, et al. Development of a patient reported disease activity score to screen for mucosal inflammation in inflammatory bowel disease. J Crohns Colitis 9:suppl 1 (2015), S192–S193.
25. Morisky, DE, Green, LW, Levine, DM, Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986), 67–74.
26. Irvine, EJ, Zhou, Q, Thompson, AK, The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 91 (1996), 1571–1578.
27. Keefer, L, Kiebles, JL, Taft, TH, The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis 17 (2011), 614–620.
28. van den Heuvel, TR, Jonkers, DM, Jeuring, SF, et al. Cohort profile: the Inflammatory Bowel Disease South Limburg Cohort (IBDSL). Int J Epidemiol, 2015 published online Jun 4. DOI:10.1093/ije/dyv088.
29. Berwick, DM, Nolan, TW, Whittington, J, The triple aim: care, health, and cost. Health Aff (Millwood) 27 (2008), 759–769.
30. Sulz, MC, Siebert, U, Arvandi, M, et al. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenterol Hepatol 25 (2013), 790–797.
31. Feuerstein, JD, Castillo, NE, Siddique, SS, et al. Poor documentation of inflammatory bowel disease quality measures in academic, community, and private practice. Clin Gastroenterol Hepatol, 14, 2016, 421 28.e2.
32. Rudin, RS, Bates, DW, MacRae, C, Accelerating innovation in health IT. N Engl J Med 375 (2016), 815–817.